Antibodies to tissue‐type plasminogen activator (t‐PA) in patients with inflammatory bowel disease: high prevalence, interactions with functional domains of t‐PA and possible implications in thrombosis
Open Access
- 20 June 2006
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (7) , 1510-1516
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolismBlood, 2004
- The Putative Mechanism of Thrombosis in Antiphospholipid Syndrome: Impairment of the Protein C and the Fibrinolytic Systems by Monoclonal Anticardiolipin AntibodiesSeminars in Thrombosis and Hemostasis, 1999
- Thrombotic vascular risk factors in inflammatory bowel disease.Gut, 1996
- Serum antibodies to distinct epitopes of the tissue‐type plasminogen activator (t‐PA) in patients with systemic lupus erythematosusAmerican Journal of Hematology, 1995
- Fibrinolytic Split Products, Fibrinolysis, and Factor XIII Activity in Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1995
- Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.Gut, 1992
- Enhanced Local Production of Complement Components in the Small Intestines of Patients with Crohn's DiseaseNew England Journal of Medicine, 1990
- Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces.Gut, 1989
- Autoimmunity to Pancreatic Juice in Crohn's Disease Results of an Autoantibody Screening in Patients with Chronic Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1987
- Cortisone in Ulcerative ColitisBMJ, 1955